Multiple Myeloma
Conditions
Brief summary
The hypothesis is that the implementation of an initial Pharmaceutical Consultation (PC) program based on the provision of standardized information to patients treated for multiple myeloma as a first course of chemotherapy, could optimize their compliance with the delivered per os treatment. The aim of this study is therefore to develop a standardised reference guide of information to be provided during prostate cancer in order to optimise the compliance of patients treated for multiple myeloma as a first course of chemotherapy per os.
Interventions
None listed
Sponsors
Centre Hospitalier Universitaire de Nīmes
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patient must be a member or beneficiary of a health insurance plan * The patient is at least 18 years old * The patient is treated for multiple myeloma, is naive to any treatment and begins a chemotherapy protocol with oral therapy and whose course of care includes a stay in the Day Hospital or retrocessions. Criteria for non-inclusion * The subject is participating in another study * The subject is in an exclusion period determined by a previous study * The subject is under the protection of justice, guardianship or curatorship * It is impossible to give informed information about * The patient is pregnant, parturient, or breastfeeding * The patient receives a follow-up by a home nurse for the administration of oral medication * The patient is treated only with oral chemotherapy in the city * The patient has early dementia. Translated with www.DeepL.com/Translator \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| evaluating the understanding | Day 1 | Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution. |
| evaluating understanding | Day 1 | Questionnaire. qualitative variables: measurement of their number and |
| evaluating the quality of information | Day 1 | Questionnaire. quantitative variables: measurement of the mean and standard deviation or by their median and quartiles according to their distribution. |
| evaluating quality of information | Day 1 | Questionnaire. qualitative variables: measurement of their number and percentage. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The time required for the pharmaceutical consultation | Day 1 | minutes |
| satisfaction des patients | Day 1 | by an Analogue Visual Scale (0-10-very satisfied) |
Countries
France
Outcome results
None listed